- Tytuł:
-
Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with
Graves ' Orbitopathy. - Autorzy:
- Źródło:
- Cells [Cells] 2021 Nov 16; Vol. 10 (11). Date of Electronic Publication: 2021 Nov 16.
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Fibroblasts/*pathology
Glycine/*analogs & derivativesGraves Ophthalmopathy /*diagnosisGraves Ophthalmopathy /*pathologyOrbit /*pathology
Pyrazoles/*pharmacology
Pyridines/*pharmacology
Receptors, Prostaglandin E, EP2 Subtype/*agonists
Spheroids, Cellular/*pathology
Cell Size/drug effects ; Cytokines/metabolism ; Endoplasmic Reticulum Stress/drug effects ; Endoplasmic Reticulum Stress/genetics ; Extracellular Matrix/genetics ; Extracellular Matrix/metabolism ; Fibroblasts/drug effects ; Gene Expression Regulation/drug effects ; Glycine/pharmacology ;Graves Ophthalmopathy /genetics ; Humans ; Isoquinolines/pharmacology ; Protein Kinase Inhibitors/pharmacology ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Receptor, IGF Type 1/metabolism ; Receptors, Prostaglandin E, EP2 Subtype/metabolism ; Receptors, Thyrotropin/metabolism ; Spheroids, Cellular/drug effects ; Sulfonamides/pharmacology ; rho-Associated Kinases/antagonists & inhibitors ; rho-Associated Kinases/metabolism
Czasopismo naukowe